Albumin-conjugated paclitaxel (nab-paclitaxel) was shown to reduce the CDA protein by producing reactive oxygen species in a mouse pancreatic cancer model; this evidence may explain the usefulness of gemcitabine plus nab-paclitaxel (GnP)[54]. The gene discussed is CDA; the disease is familial pancreatic carcinoma.